Matt Patterson is Chairman of the Board of Directors of Vor Biopharma, Inc., Executive Chairman of the Board of Directors of Remix Therapeutics, Inc. and a member of the Board of Directors at Homology Medicines, Inc. Previously, he co-founded Audentes Therapeutics and served as Chief Executive Officer from the Company’s inception in November 2012 until its acquisition by Astellas Pharma Inc. in January 2020. He was also Chairman of the Board of Directors and formerly served as President until May 2018. Previously, Matt worked for Genzyme Corporation, BioMarin Pharmaceutical, and Amicus Therapeutics. Prior to Audentes he was an Entrepreneur-In-Residence with OrbiMed. He also served as a member of the Board of Directors of the Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cell therapy and broader regenerative medicine sector, from 2015-2021, and was Chairman in 2019 and 2020.
Yael Weiss, Mahzi
Peter Marks, FDA